The US ePharmacy Market is projected to grow from $21 Bn in 2022 to $86 Bn by 2030, registering a CAGR of 19.3% during the forecast period of 2022-2030. The US ePharmacy market is driven by a number of factors, including the increasing demand for convenient and cost-effective healthcare solutions, the rise in chronic diseases and the aging population, and the growing adoption of technology in the healthcare industry. CVS Health is one of the largest ePharmacy players in the United States, with a market share of around 25%. The company offers a range of services, including prescription fulfillment, mail-order delivery, and specialty pharmacy services.
The term "ePharmacy," commonly referred to as "online pharmacy" or "internet pharmacy," describes the marketing and delivery of prescription drugs and other healthcare items via online channels. ePharmacies allow patients to buy prescriptions from the comfort of their homes and have them delivered right to their doorsteps, making them a practical and affordable alternative to conventional brick-and-mortar pharmacies.
Prescription fulfillment, mail-order delivery, and telemedicine consultations with medical experts are just a few of the services that ePharmacies often provide. Specialty pharmacy services, such as drugs for long-term disorders like diabetes, cancer, or autoimmune diseases, are also provided by several online pharmacies.
The US ePharmacy Market is anticipated to expand from $21 Bn in 2022 to $86 Bn in 2030, showing a CAGR of 19.3% from 2022 to 2030.
The sale and distribution of pharmaceutical items via online channels is a component of the US ePharmacy business, a segment of the healthcare industry that is expanding quickly. The COVID-19 epidemic has sped up the expansion of the US ePharmacy sector as more people choose to buy their prescription medications and healthcare products online.
The US ePharmacy business is fiercely competitive, with many firms active in different market areas. A variety of reasons, including the rising prevalence of chronic illnesses and the aging population, the expanding acceptance of technology in the healthcare sector, and the rising desire for accessible and affordable healthcare solutions, are driving the US ePharmacy market. Nevertheless, the industry also has to deal with a number of difficulties, including legal and regulatory problems, worries about patient privacy and safety, and the possibility of cyberattacks and data breaches.
In general, it is anticipated that the US ePharmacy industry will maintain its upward trend as more people choose online shopping choices for their prescription medication and healthcare requirements. Technology advancements, alterations in consumer behavior, and the growing demand for practical and affordable healthcare solutions are all predicted to contribute to this trend.
Market Growth Drivers
There are a number of important variables driving the US ePharmacy market, including:
In general, ePharmacies' convenience, cost savings, and improved access to drugs are fueling this market's expansion in the US. The industry is anticipated to maintain its development trajectory in the next years as more customers become accustomed to obtaining their prescriptions online.
Key Players
The ePharmacy market is fiercely competitive in the United States, where a few major competitors dominate the industry. The following are a few of the top businesses in the US ePharmacy market:
As they are created to safeguard the safety and efficacy of drugs and other healthcare items, healthcare laws and regulations play a vital role in the US ePharmacy business. The following are some of the main laws and rules that have an effect on the American ePharmacy market:
Regulations of the Drug Enforcement Administration (DEA) Prescription opioids, which are often dispensed through ePharmacies, are among the prohibited drugs that are handled and distributed in accordance with DEA regulations. Regulations set out by the DEA must be followed by ePharmacies in order to verify and fill prescriptions for restricted medications.
Regulations of the Food and Drug Administration (FDA): The FDA is in charge of policing the efficacy and safety of pharmaceuticals, medical devices, and other healthcare items. For the handling and dispensing of prescription pharmaceuticals, including the requirements for labelling, storage, and record-keeping, EPharmacies are subject to FDA rules.
Rules for Telemedicine: State and federal laws governing the practice of telemedicine must be followed by ePharmacies that provide telemedicine services. These rules may include those for licensure, informed consent, and patient privacy, and they can differ by state.
Health Insurance Portability and Accountability Act (HIPAA): HIPAA laws, which set national standards for the privacy and security of PHI, must be followed by ePharmacies that handle protected health information (PHI).
Drug Pricing Regulations: The US government controls drug prices using a number of different methods, such as the Medicaid Drug Rebate Program, which requires pharmaceutical companies to give rebates to state Medicaid programs, and the 340B Drug Pricing Program, which gives certain healthcare providers discounts on outpatient medications.
Overall, the regulatory environment for ePharmacies in the United States is complicated and continuously changing as new laws and rules are put in place to guarantee the security and efficacy of medical supplies and services. To achieve compliance and preserve customer trust, ePharmacies must remain current with these laws and modify its business practices accordingly.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
Drug type
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The US ePharmacy Market is projected to grow from $21 Bn in 2022 to $86 Mn by 2030, registering a CAGR of 19.3% during the forecast period of 2022 - 2030.
The ePharmacy market in the United States is highly competitive, with several key players dominating the market. Here are some of the leading companies in the US ePharmacy market:
CVS Health
Walgreens Boots Alliance
Walmart
Amazon
Capsule
Ro.
This report addresses
Need more?